Kevin Marsh/Br J Clin Pharmacol

Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.Mithwani S, Aarons L, Kokwaro GO, Majid O, Muchohi S, Edwards G, Mohamed S, Marsh K, Watkins W
Br J Clin Pharmacol, (2004). 57:146-52

Management of severe malaria: implications for research.Marsh K
Br J Clin Pharmacol, (2003). 55:460-3

Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions.Ogutu BR, Newton CR, Crawley J, Muchohi SN, Otieno GO, Edwards G, Marsh K, Kokwaro GO
Br J Clin Pharmacol, (2002). 53:49-57

Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.Watkins WM, Winstanley PA, Mberu EK, Kokwaro G, Murphy SA, Newton CJ, Mwangi I, Forster D, Marsh K
Br J Clin Pharmacol, (1995). 39:283-7

Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects.Winstanley PA, Newton CR, Pasvol G, Kirkham FJ, Mberu E, Peshu N, Ward SA, Were JB, Warrell DA, Marsh K
Br J Clin Pharmacol, (1992). 33:149-54

The disposition of oral and intramuscular pyrimethamine/sulphadoxine in Kenyan children with high parasitaemia but clinically non-severe falciparum malaria.Winstanley PA, Watkins WM, Newton CR, Nevill C, Mberu E, Warn PA, Waruiru CM, Mwangi IN, Warrell DA, Marsh K
Br J Clin Pharmacol, (1992). 33:143-8